8 Apr 2021 13:03
 Ap19
Â
Â
FORMÂ 8.3
Â
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
DEALINGSÂ BYÂ PERSONSÂ WITHÂ INTERESTSÂ INÂ RELEVANTÂ SECURITIESÂ REPRESENTINGÂ 1%Â ORÂ MORE
Â
1. KEYÂ INFORMATION
Â
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | AON plc |
Class of relevant security to which the dealings being disclosed relate (Note 2) | US$0.01 ordinary shares |
Date of dealing | Â 07 April 2021 |
Â
2. INTERESTSÂ ANDÂ SHORTÂ POSITIONS
Â
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 | Long | Short | ||||
 | Number |  | (%) | Number |  | (%) |
(1) Relevant securities | 6,302,594 2.79 | 2,042,924 0.90 | ||||
(2) Derivatives (other than options) | 1,765,199 0.78 | 37,125 0.02 | ||||
(3) Options and agreements to purchase/sell | Â | 300,000 0.13 | ||||
Total | 8,067,793 3.57 | 2,380,049 1.05 | ||||
 |  |  |  |  |  |  |
Â
Â
Ap20
Â
Â
1. DEALINGS (Note 4)
Â
(a) Purchases and sales
Â
 Purchase/sale |  Number of relevant securities |  Price per unit (USD)   (Note 5) | |
Purchase(New Borrow)  Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases  Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales | 52,000  51  100  1  6  6  20  15  15  1  4  1  1  15  31  100  300  432  1,790  100  1  40  5  3,165  35  633  21  21  350  7  1,274  200  1,250  28  105  11  11  61  133  207  72  2,410  6  39  39  2  84   28  6  15  15  28  432  20  3,165  35  633  5  21  15  7  734  1,274  233  200  4  100  8  28  105  98  160  207  2,589  2  2  84 | N/A  233.8100 USD 234.1400 USD 234.3400 USD 234.4000 USD 234.4033 USD 234.4100 USD 234.4600 USD 234.4827 USD 234.6000 USD 234.6225 USD 234.6500 USD 234.7100 USD 234.7200 USD 234.7700 USD 234.7900 USD 234.8050 USD 234.8113 USD 234.8180 USD 234.8700 USD 235.0200 USD 235.1200 USD 235.2680 USD 235.2898 USD 235.3057 USD 235.3186 USD 235.5290 USD 235.5881 USD 235.5916 USD 235.8300 USD 235.8418 USD 235.8550 USD 235.9146 USD 236.0200 USD 236.0287 USD 236.0327 USD 236.0650 USD 236.0900 USD 236.0936 USD 236.1137 USD 236.1333 USD 236.2700 USD 236.2800 USD 236.2833 USD 236.2997 USD 236.3100 USD 236.3600 USD
233.4550 USD 234.4033 USD 234.4827 USD 234.5900 USD 234.6350 USD 234.8113 USD 235.0300 USD 235.2898 USD 235.3057 USD 235.3186 USD 235.5280 USD 235.5881 USD 235.5887 USD 235.8300 USD 235.8359 USD 235.8418 USD 235.8500 USD 235.8550 USD 235.9900 USD 236.0000 USD 236.0129 USD 236.0200 USD 236.0287 USD 236.0300 USD 236.0900 USD 236.1137 USD 236.2700 USD 236.3100 USD 236.3200 USD 236.3600 USD | |
 |  |  |  |
Â
(b) Derivatives transactions (other than options transactions)
Â
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
Equity Swap | Decrease Long   Increase Long  Increase Short  Opening a short position | 432  35  633  21  1,274  3,064  101  6 | 234.8113 USD 235.3057 USD 235.3186 USD 235.5881 USD 235.8418 USD 235.2575 USD 236.2700 USD 234.4033 USD |
Â
Â
Â
Â
(c) Options transactions in respect of existing relevant securities
Â
Â
(i) Writing, selling, purchasing or varying
Â
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price (USD) | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
 |  |  |  |  |  |  |
Â
(ii) Exercising
Â
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
 |  |  |
Â
Â
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Â
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
 |  |  |
Â
Ap21
Â
2. OTHERÂ INFORMATION
Â
Agreements, arrangements or understandings relating to options or derivatives
Â
Â
Â
Â
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of anyrelevant securities to which any derivative referred to on this form is referenced. If none, thisshould be stated.
Â
None
Â
Â
Â
Â
Â
Â
Is a Supplemental Form 8 attached? (Note 9)  Yes
Â
Date of disclosure | 08 April 2021 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |
Â
 Â
Â
SUPPLEMENTALÂ FORMÂ 8
Â
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
Â
Â
Â
DETAILSÂ OFÂ OPENÂ POSITIONS
Â
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
Â
OPEN POSITIONS (Note 1)
Â
Â
Â
Product name, e.g. call option | Written, or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2) | Type, e.g. American, European etc. | Expiry date |
Call Option Call Option Call Option Call Option | Written Written Written Written | 46,200 Â 71,700 Â 77,400 Â 104,700 | 270.00 270.00 270.00 270.00 | American American American American | 17/12/2021 17/12/2021 17/12/2021 17/12/2021 |
Â
Â
Notes
Â
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given.Full details of any existing agreements to purchase or to sell must also be given on this form.
Â
2. For all prices and other monetary amounts, the currency must be stated.
Â
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
Â
Â
Â
Â
Â
Â